Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan: Comparison with the first surveillance report.

Anti-Bacterial Agents / pharmacology Azithromycin / pharmacology Chlamydia trachomatis Drug Resistance, Bacterial Humans Japan / epidemiology Male Microbial Sensitivity Tests Urethritis / drug therapy
Antimicrobial susceptibility Chlamydia trachomatis Surveillance

Journal

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 15 08 2021
revised: 15 09 2021
accepted: 17 09 2021
pubmed: 29 9 2021
medline: 20 11 2021
entrez: 28 9 2021
Statut: ppublish

Résumé

The Urogenital Sub-committee and the Surveillance Committee of the Japanese Society of Chemotherapy, The Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology conducted the second nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis. In this second surveillance study, clinical urethral discharge specimens were collected from patients with urethritis in 26 hospitals and clinics from May 2016 to July 2017. Based on serial cultures, the minimum inhibitory concentration (MIC) could be determined for 41 isolates; the MICs (MIC

Identifiants

DOI: 10.1016/j.jiac.2021.09.012 PMID: 34580009
pubmed: 34580009
pii: S1341-321X(21)00261-0
doi: 10.1016/j.jiac.2021.09.012
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Azithromycin 83905-01-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-5

Informations de copyright

Copyright © 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Auteurs

Satoshi Takahashi (S)

The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Infection Control and Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan. Electronic address: stakahas@sapmed.ac.jp.

Mitsuru Yasuda (M)

The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Urology, Graduate School of Medicine, Gifu University, Gifu, Japan.

Koichiro Wada (K)

The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Masahiro Matsumoto (M)

The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan.

Hiroshi Hayami (H)

The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Blood Purification Center, Kagoshima University Hospital, Kagoshima, Japan.

Kanao Kobayashi (K)

The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan.

Jun Miyazaki (J)

The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan.

Hiroshi Kiyota (H)

The Surveillance Committee of JSC, JAID and JSCM, Tokyo, Japan; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

Tetsuya Matsumoto (T)

The Surveillance Committee of JSC, JAID and JSCM, Tokyo, Japan.

Hiroshi Yotsuyanagi (H)

The Surveillance Committee of JSC, JAID and JSCM, Tokyo, Japan.

Kazuhiro Tateda (K)

The Surveillance Committee of JSC, JAID and JSCM, Tokyo, Japan.

Junko Sato (J)

The Surveillance Committee of JSC, JAID and JSCM, Tokyo, Japan.

Hideaki Hanaki (H)

Infection Control Research Center, Kitasato University, Tokyo, Japan.

Naoya Masumori (N)

Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.

Yoshiki Hiyama (Y)

Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.

Shin Egawa (S)

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

Hiroki Yamada (H)

Department of Urology, The Jikei University Katsushika MedicalCenter, Tokyo, Japan.

Kazumasa Matsumoto (K)

Department of Urology, Kitasato University School of Medicine, Kanagawa, Japan.

Kiyohito Ishikawa (K)

Department of Urology, Fujita Health University, Aichi, Japan.

Shingo Yamamoto (S)

Department of Urology, Hyogo College of Medicine, Nishinomiya, Japan.

Yoshikazu Togo (Y)

Department of Urology, Hyogo College of Medicine, Nishinomiya, Japan.

Kazushi Tanaka (K)

Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.

Katsumi Shigemura (K)

Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.

Shinya Uehara (S)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Hiroyuki Kitano (H)

Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Keijiro Kiyoshima (K)

Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Ryoichi Hamasuna (R)

Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan.

Kenji Ito (K)

Ito Urology Clinic, Kitakyushu, Japan.

Hideo Hirayama (H)

Hirayama Urology Clinic, Kumamoto, Japan.

Shuichi Kawai (S)

Kawai Urology Clinic, Kitakyushu, Japan.

Yutaka Shiono (Y)

Aioi 23 Clinic, Yokohama, Japan.

Takahiro Maruyama (T)

Maruyama Urology Clinic, Nagoya, Japan.

Shin Ito (S)

IClinic, Sendai, Japan.

Mutsumasa Yoh (M)

Yoh Urology and Dermatology Clinic, Inazawa, Japan.

Masayasu Ito (M)

Gifu Urological Clinic, Gifu, Japan.

Koichi Hatano (K)

Hatano Urology and Dermatology Clinic, Gifu, Japan.

Hideari Ihara (H)

Ihara Clinic, Nishinomiya, Japan.

Satoshi Uno (S)

Hirajima Clinic, Okayama, Japan.

Koichi Monden (K)

Araki Urological Clinic, Kurashiki, Japan.

Teruhiko Yokoyama (T)

Yokoyama Urological Clinic, Okayama, Japan.

Kazuo Takayama (K)

Department of Urology, Takayama Hospital, Chikushino, Japan.

Toru Sumii (T)

Sumii Clinic, Hiroshima, Japan.

Hitoshi Kadena (H)

Kadena Urological Clinic, Hiroshima, Japan.

Motoshi Kawahara (M)

Kawahara Urology Clinic, Kagoshima, Japan.

Takahide Hosobe (T)

Hosobe Clinic, Tokyo, Japan.

Masanobu Izumitani (M)

Izumitani Fureai Urological Clinic, Nagoya, Japan.

Motonori Kano (M)

Department of Urology, Kano Hospital, Fukuoka, Japan.

Hirofumi Nishimura (H)

Nishimura Urology Clinic, Kitakyushu, Japan.

Ryuji Fujita (R)

Jin-Hinyokika Nishikawahara Clinic, Okaayama, Japan.

Shinichi Kaji (S)

Kaji Clinic, Fukuoka, Japan.

Kenji Hayashi (K)

Tomakomai Urology and Cardiology Clinic, Tomakomai, Japan.

Takanori Tojo (T)

Department of Urology, Tomeiatsugi Hospital, Atsugi, Japan.

Masaru Matumura (M)

Matsumura Urology Clinic, Kato, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Nationwide surveillance of the antimicrobial...
questionsmedicales.fr › Composés chimiques organiques › Lactones › Érythromycine › Azithromycine › Nationwide surveillance of the antimicrobial...
questionsmedicales.fr › Bactéries › Bactéries à Gram négatif › Chlamydiales › Chlamydiaceae › Chlamydia › Chlamydia trachomatis › Nationwide surveillance of the antimicrobial...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › Nationwide surveillance of the antimicrobial...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Nationwide surveillance of the antimicrobial...
questionsmedicales.fr › Régions géographiques › Iles › Japon › Nationwide surveillance of the antimicrobial...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Nationwide surveillance of the antimicrobial...
questionsmedicales.fr › Maladies urogénitales › Maladies urologiques › Maladies de l'urètre › Urétrite › Nationwide surveillance of the antimicrobial...